Recombinant multi-species CBX5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CBX5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a highly conserved nonhistone protein, which is a member of the heterochromatin protein family. The protein is enriched in the heterochromatin and associated with centromeres. The protein has a single N-terminal chromodomain which can bind to histone proteins via methylated lysine residues, and a C-terminal chromo shadow-domain (CSD) which is responsible for the homodimerization and interaction with a number of chromatin-associated nonhistone proteins. The encoded product is involved in the formation of functional kinetochore through interaction with essential kinetochore proteins. The gene has a pseudogene located on chromosome 3. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 2610029O15Rik,Antigen p25,CBX5,Cbx5,Chromobox protein homolog 5,HEL25,HP1,HP1A,HP1alpha,Heterochromatin protein 1 homolog alpha (HP1 alpha),Hp1a,Hp1alpha
Go
to CBX5 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP6892-Ag-1/ GM-Tg-hg-IP6892-Ag-2 | Human CBX5 protein | Human |
| GM-Tg-rg-IP6892-Ag-1/ GM-Tg-rg-IP6892-Ag-2 | Rat CBX5 protein | Rat |
| GM-Tg-mg-IP6892-Ag-1/ GM-Tg-mg-IP6892-Ag-2 | Mouse CBX5 protein | Mouse |
| GM-Tg-cynog-IP6892-Ag-1/ GM-Tg-cynog-IP6892-Ag-2 | Cynomolgus/Rhesus macaque CBX5 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP6892-Ag-1/ GM-Tg-felg-IP6892-Ag-2 | Feline CBX5 protein | Feline |
| GM-Tg-cang-IP6892-Ag-1/ GM-Tg-cang-IP6892-Ag-2 | Canine CBX5 protein | Canine |
| GM-Tg-bovg-IP6892-Ag-1/ GM-Tg-bovg-IP6892-Ag-2 | Bovine CBX5 protein | Bovine |
| GM-Tg-equg-IP6892-Ag-1/ GM-Tg-equg-IP6892-Ag-2 | Equine CBX5 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP6892-Ag-1/ GM-Tg-hg-IP6892-Ag-2;
GM-Tg-rg-IP6892-Ag-1/ GM-Tg-rg-IP6892-Ag-2;
GM-Tg-mg-IP6892-Ag-1/ GM-Tg-mg-IP6892-Ag-2; GM-Tg-cynog-IP6892-Ag-1/ GM-Tg-cynog-IP6892-Ag-2; GM-Tg-felg-IP6892-Ag-1/ GM-Tg-felg-IP6892-Ag-2; GM-Tg-cang-IP6892-Ag-1/ GM-Tg-cang-IP6892-Ag-2; GM-Tg-bovg-IP6892-Ag-1/ GM-Tg-bovg-IP6892-Ag-2; GM-Tg-equg-IP6892-Ag-1/ GM-Tg-equg-IP6892-Ag-2 |
| Products Name | CBX5 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CBX5 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CBX5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.